Exelixis
EXEL
#1767
Rank
$11.23 B
Marketcap
$41.72
Share price
-1.06%
Change (1 day)
18.64%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company